In addition, another methyltransferase, PRDM12, was mapped to the minimal deleted region flanking ABL and BCR genes in a set of CML patients with unfavorable prognosis, figuring as a strong candidate tumor suppressor gene [4]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.